COVID-19 vaccines ‘highly effective’ against B1.617.2 variant: UK research Press Trust of India May 23, 2021 PHE said that while the Pfizer/BioNTech vaccine was 88 per cent effective against symptomatic COVID-19 from the B1.617.2 variant…
